Malignant Neoplasms of Brain: Clinical Trials

4 trials for Malignant Neoplasms of Brain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 2 Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Not applicable1Recruiting 1
Phase 21Completed 1

Follow Malignant Neoplasms of Brain: new trials by email Literature Review of Malignant Neoplasms of Brain trials Research Report on Malignant Neoplasms of Brain

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Application of the CD73-Targeted Probe ⁶⁸Ga-DOTA-mPNE PET/CT Imaging in the Diagnosis of Malignant Tumors
68Ga-DOTA-mPNE - Malignant Neoplasms of Brain
Not applicableRecruitingPeking Union Medical College Hospital502025-07-102025-08-05
Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
PEP-3 vaccine, sargramostim, Temozolomide - Malignant Neoplasms of Brain
Phase 2CompletedJohn Sampson402007-09-012017-02-01
Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery
PEP-3-KLH conjugate vaccine, daclizumab, temozolomide - Malignant Neoplasms of Brain
Phase 1CompletedJohn Sampson162007-03-012016-01-21
Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous lymphocytes - Malignant Neoplasms of Brain
Phase 1CompletedGary Archer Ph.D.422006-02-062023-03-13

Narrower conditions

Glioblastoma (3)  ·  Gliosarcoma (3)  ·  Glioma (1)

Broader conditions

Astrocytoma (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neoplasms, Neuroepithelial (3)  ·  Neuroectodermal Tumors (3)  ·  Glioma (2)

Interventions

Temozolomide (2)  ·  Daclizumab (1)  ·  Tetanus Toxoid (1)  ·  rindopepimut (1)  ·  sargramostim (1)

Sponsors

John Sampson (2)  ·  Gary Archer Ph.D. (1)  ·  Peking Union Medical College Hospital (1)

Countries

United States (3)  ·  China (1)

Top investigators

Duane Mitchell, MD, PhD (1)  ·  Gordana Vlahovic, MD (1)  ·  Katherine Peters, MD, PhD (1)  ·  Xianzhong Zhang, PhD (1)

Results publications

PMID 18775433, PMID 20921459, PMID 21149254, PMID 22383993, PMID 25762141, PMID 28411277

NIH funding

P50NS020023 (1), R21CA132891 (1)